Articles dans des revues avec comité de lecture (17)
  1. 1. Gemander, N., Neumann, J., Veiga, R., Etienne, I., Prezzemolo, T., Kemlin, D., Pannus, P., Depickère, S., Olislagers, V., Vu Duc, I., Waegemans, A., Gerbaux, M., Bücken, L., Dahma, H., Martin, C., Dauby, N., Goossens, M. M., Desombere, I., Roca, C. P., Willemsen, M., Goriely, S., Le Moine, A., Marchant, A., Liston, A., & Humblet-Baron, S. (2025). Systems vaccinology identifies immunological correlates of SARS-CoV-2 vaccine response in solid organ transplant recipients. NPJ vaccines, 10(1), 140. doi:10.1038/s41541-025-01182-1
  2. 2. Gemander, N., Kemlin, D., Depickère, S., Kelkar, N. N., Sharma, S., Pannus, P., Waegemans, A., Olislagers, V., Georges, D., Dhondt, E., Braga, M., Heyndrickx, L., Michiels, J., Thiriard, A., Lemy, A., Baudoux, T., Vandevenne, M., Goossens, M. M., Matagne, A., Desombere, I., Ariën, K., Ackerman, M. M., Le Moine, A., & Marchant, A. (2025). COVID-19 vaccine responses are influenced by distinct risk factors in naive and SARS-CoV-2 experienced hemodialysis recipients. Vaccine, 44, 126544. doi:10.1016/j.vaccine.2024.126544
  3. 3. Gemander, N., Kemlin, D., Depickère, S., Kelkar, N. N., Pannus, P., Sharma, S., Waegemans, A., Olislagers, V., Georges, D., Dhondt, E., Braga, M., Heyndrickx, L., Michiels, J., Thiriard, A., Lemy, A., Vandevenne, M., Goossens, M. M., Matagne, A., Desombere, I., Ariën, K., Ackerman, M. M., Le Moine, A., & Marchant, A. (2024). Hybrid Immunity Overcomes Defective Immune Response to COVID-19 Vaccination in Kidney Transplant Recipients. Kidney International Reports, 9(3), 635-648. doi:10.1016/j.ekir.2023.12.008
  4. 4. Sharma, S., Thiriard, A., Olislagers, V., Lechien, J. R., Jurion, M.-H., Delforge, M.-L., Marchant, A., & Saussez, S. (2024). Mucosal antibody response and SARS-CoV-2 shedding in patients with COVID-19 related olfactory dysfunction. Journal of medical virology, 96(1), e29398. doi:10.1002/jmv.29398
  5. 5. Etienne, I., Kemlin, D., Gemander, N., Olislagers, V., Waegemans, A., Dhondt, E., Heyndrickx, L., Depickère, S., Charles, A., Goossens, M. M., Vandermosten, L., Desombere, I., Ariën, K., Pannus, P., Knoop, C., & Marchant, A. (2024). Persistent defect in SARS-CoV-2 humoral and cellular immunity in lung transplant recipients. The Journal of heart and lung transplantation. doi:10.1016/j.healun.2024.08.002
  6. 6. Pannus, P., Depickère, S., Kemlin, D., Georges, D., Houben, S., Olislagers, V., Waegemans, A., De Craeye, S., Francotte, A., Chaumont, F., Van Oostveldt, C., Heyndrickx, L., Michiels, J., Willems, E., Dhondt, E., Krauchuk, M., Schmickler, M.-N., Verbrugghe, M., Van Loon, N., Dierick, K., Matagne, A., Desombere, I., Ariën, K. K., Marchant, A., & Goossens, M. M. (2023). Third dose of COVID-19 mRNA vaccine closes the gap in immune response between naïve nursing home residents and healthy adults. Vaccine, 41(17), 2829-2836. doi:10.1016/j.vaccine.2023.03.047
  7. 7. Kemlin, D., Gemander, N., Depickère, S., Olislagers, V., Georges, D., Waegemans, A., Pannus, P., Lemy, A., Goossens, M. M., Desombere, I., Michiels, J., Vandevenne, M., Heyndrickx, L., Ariën, K. K., Matagne, A., Ackerman, M. M., Le Moine, A., & Marchant, A. (2023). Humoral and cellular immune correlates of protection against COVID-19 in kidney transplant recipients. American Journal of Transplantation. doi:10.1016/j.ajt.2023.02.015
  8. 8. Tomasi, L., Thiriard, A., Heyndrickx, L., Georges, D., Van den Wijngaert, S., Olislagers, V., Sharma, S., Matagne, A., Ackerman, M. M., Ariën, K. K., Goetghebuer, T., & Marchant, A. (2022). Younger Children Develop Higher Effector Antibody Responses to SARS-CoV-2 Infection. Open Forum Infectious Diseases, 9(11), ofac554. doi:10.1093/ofid/ofac554
  9. 9. Lavis, P., Morra, S., Orte Cano, C., Albayrak, N., Corbiere, V., Olislagers, V., Dauby, N., Del Marmol, V., Marchant, A., Decaestecker, C., Mascart, F., De Vos, N., Van De Borne, P., Salmon, I., Remmelink, M., Parmentier, M., Cardozo, A. K., & Bondue, B. (2022). Chemerin plasma levels are increased in COVID-19 patients and are an independent risk factor of mortality. Frontiers in immunology, 13, 941663. doi:10.3389/fimmu.2022.941663
  10. 10. Brauns, E., Azouz, A., Grimaldi, D., Xiao, H., Thomas, S., Nguyen, M., Olislagers, V., Vu Duc, I., Orte Cano, C., Del Marmol, V., Pannus, P., Libert, F., Saussez, S., Dauby, N., Das, J., Marchant, A., & Goriely, S. (2022). Functional reprogramming of monocytes in patients with acute and convalescent severe COVID-19. JCI insight, 7(9). doi:10.1172/jci.insight.154183
  11. 11. Pannus, P., Depickère, S., Kemlin, D., Houben, S., Neven, K. Y., Heyndrickx, L., Michiels, J., Willems, E., De Craeye, S., Francotte, A., Chaumont, F., Olislagers, V., Waegemans, A., Verbrugghe, M., Schmickler, M.-N., Van Gucht, S., Dierick, K., Marchant, A., Desombere, I., Ariën, K. K., & Goossens, M. M. (2022). Safety and immunogenicity of a reduced dose of the BNT162b2 mRNA COVID-19 vaccine (REDU-VAC): A single blind, randomized, non-inferiority trial. PLOS global public health, 2(12), e0001308. doi:10.1371/journal.pgph.0001308
  12. 12. Saussez, S., Sharma, S., Thiriard, A., Olislagers, V., Vu Duc, I., Le Bon, S.-D., Khalife, M., Hans, S., De Riu, G., Hopkins, C., Lechien, J., Vaira, L., & Marchant, A. (2021). Predictive factors of smell recovery in a clinical series of 288 coronavirus disease 2019 patients with olfactory dysfunction. European journal of neurology, 28(11), 3702-3711. doi:10.1111/ene.14994
    13. << Précédent 1 2 Suivant >>